Eileen Dimalanta is a senior-level scientist and the Senior Director of Assay Development at Foundation Medicine. With extensive experience in product development for next-generation sequencing and enzymatic assays, she has a proven track record of launching over 70 products in ten years. She holds a Bachelor of Science from Columbia University and a Master of Science from New York University.
She frequently attends major industry conferences like AACR and ASCO to connect with colleagues and exchange ideas that advance cancer research and innovation. Eileen actively seeks opportunities for collaboration and networking within the oncology community.
Unique fact: Eileen is a co-author on multiple scientific publications and abstracts related to next-generation sequencing, ctDNA methyl sequencing, and DNA repair.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.